Results 151 to 160 of about 7,107 (213)

Advances in Duchenne Muscular Dystrophy: Diagnostic Techniques and Dystrophin Domain Insights. [PDF]

Int J Mol Sci
Sarvutiene J, Ramanavicius A, Ramanavicius S, Prentice U.   +3 more
europepmc   +1 more source

Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies. [PDF]

Cell Mol Life Sci
Łoboda A, Dulak J.
europepmc   +1 more source

Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review. [PDF]

BioDrugs
Szwec S, Kapłucha Z, Chamberlain JS, Konieczny P.   +3 more
europepmc   +1 more source

Upregulation of utrophin improves the phenotype of Duchenne muscular dystrophy hiPSC-derived CMs. [PDF]

Mol Ther Nucleic Acids
Andrysiak K, Ferdek PE, Sanetra AM, Machaj G, Schmidt L, Kraszewska I, Sarad K, Palus-Chramiec K, Lis O, Targosz-Korecka M, Krüger M, Lewandowski MH, Ylla G, Stępniewski J, Dulak J.   +14 more
europepmc   +1 more source

Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy. [PDF]

Mol Ther
Le Guiner C, Toumaniantz G, Larcher T, Marchand S, Buscara L, Cedrone G, Moreira CV, Lancelot A, Georger C, Lafoux A, Couzinié C, Augereau D, Jounier C, Hivonnait A, Creoff E, Blaie S, Huchet C, Adjali O, Daniele N, Perret G, Braun S.   +20 more
europepmc   +1 more source

Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy. [PDF]

Skelet Muscle
Lee YI, Hart CC, Henley-Beasley CS, Herr JS, Zerpa E, Barton ER, Hammers DW, Sweeney HL.   +7 more
europepmc   +1 more source

AKT Signaling Regulates Agrin-Mediated Acetylcholine Receptor Surface Density. [PDF]

Medicina (Kaunas)
Jaiswal N, Lin NR, Lehnen CF, Tariq A, Lukov LL, Zhang C.   +5 more
europepmc   +1 more source

CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions. [PDF]

DNA (Basel)
Srinivasa MA, Escobar M.
europepmc   +1 more source

Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle. [PDF]

Elife
Miyazaki D, Sato M, Shiba N, Yoshizawa T, Nakamura A.   +4 more
europepmc   +1 more source

Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy. [PDF]

Neurol Int
Krishna L, Prashant A, Kumar YH, Paneyala S, Patil SJ, Ramachandra SC, Vishwanath P.   +6 more
europepmc   +1 more source